More about
Primary Progressive Multiple Sclerosis
News
September 13, 2024
1 min read
Save
FDA approves first twice-a-year, subcutaneous injection for multiple sclerosis
Genentech announced it received FDA approval for Ocrevus Zunovo to treat patients with relapsing and primary progressive multiple sclerosis, according to a company press release.